Evolus EOLS
NASDAQ EOLS
$7.99 +0.03 (+0.38%)
At close: Sep 29, 2026 · 4:00 PM EDT

Evolus (EOLS) Gross Margin (2019 - 2026)

Updated

Evolus (EOLS) posted Gross Margin of 68.00% for Q2 2026, up 2.69 percentage points from 65.31% a year earlier and up 1.15 percentage points from the prior quarter.

Analysis

Evolus (EOLS) Gross Margin (2019 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Gross Margin at Evolus was 66.74%, down 0.44 percentage points year-over-year; for FY2025, it came in at 66.33%, down 2.14 percentage points from FY2024.

  • Annual Gross Margin shows a five-year change of -1.31 percentage points (FY2020 to FY2025).
  • In prior years, Evolus' Gross Margin was 68.46% in FY2024 (+0.39 pp), 68.08% in FY2023 (+7.67 pp), 60.41% in FY2022 (+4.08 pp) and 56.32% in FY2021 (-11.31 pp).
  • The Q2 2026 figure stands as the highest quarterly Gross Margin since Q1 2025.
  • On a year-over-year basis, Gross Margin increased in two of the last eight quarters, with an average year-over-year change of -0.54 percentage points.
  • The strongest year-over-year quarter for Gross Margin in the past five years was Q2 2023, with a gain of 12.75 percentage points; the weakest was Q3 2021, with a drop of 15.59 percentage points.
  • According to Business Quant data, Gross Margin for the three prior quarters was 66.86% (Q1 2026), 65.66% (Q4 2025) and 66.47% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 68.19%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 74.74%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 73.54%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 78.02%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 83.60%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 72.04%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 79.76%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 85.33%
10 Evolus 525.47 Mn 333.16 Mn 57.18 Mn 68.00%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 68.00%
Mar 31, 2026 66.86%
Dec 31, 2025 65.66%
Sep 30, 2025 66.47%
Jun 30, 2025 65.31%
Mar 31, 2025 68.09%
Dec 31, 2024 66.67%
Sep 30, 2024 68.92%
Jun 30, 2024 70.35%
Mar 31, 2024 68.26%
Dec 31, 2023 63.56%
Sep 30, 2023 69.15%
Jun 30, 2023 70.19%
Mar 31, 2023 70.89%
Dec 31, 2022 62.60%
Sep 30, 2022 60.21%
Jun 30, 2022 57.43%
Mar 31, 2022 61.05%
Dec 31, 2021 54.31%
Sep 30, 2021 56.93%
API Access

Evolus Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=EOLS&period=max&api_key=YOUR_API_KEY